You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 

You are reading 1 of 2 free-access articles allowed for 30 days

PSI concerned over ulcer drug dispensing errors

By Mindo - 04th Jun 2019 | 6 views

Shot of a young mother taking her baby daughter for a checkup at the doctor’s office

The Pharmaceutical Society of Ireland (PSI) has expressed concern over dispensing errors by pharmacists when supplying Zantac Syrup to paediatric patients.

In children (aged three-to-18 years), Zantac Syrup is indicated for the short-term treatment of peptic ulcer and treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.

According to the report of the PSI registrar in February, “further to previous recommendations” from the professional conduct committee on this matter, the Society was writing to the marketing authorisation holder (MAH) and Health Products Regulatory Authority (HPRA) to propose “actions to facilitate safer care”.

“The PSI is suggesting changes to the packaging and the formulation of Zantac Syrup, which may reduce the risk of dispensing errors when this product is supplied by pharmacists to paediatric patients,” according to the report. “As the safety issues which have come to our attention relate to dose miscalculations, the PSI is also writing to the schools of pharmacy, in an advisory capacity, to alert them to this particular safety issue.”

A PSI spokesperson told the Medical Independent (MI) it had recently raised with the HPRA “that we wish to engage with them to explore this matter further”.

The PSI has received five complaints that relate to errors in the dispensing of this medication in paediatric patients. Of the five complaints, four inquiries have been conducted and concluded before the professional conduct committee between 2014 and 2018.  “Any action in relation to the fifth complaint is not concluded.”

A HPRA spokesperson informed MI: “Since authorisation in 1989, the HPRA has received two reports of medication errors in association with Zantac Syrup. In one case, the error was intercepted prior to treatment and no adverse reaction/event was experienced. In the second case, the patient concerned was reported to have experienced vomiting and diarrhoea.”

A spokesperson for GSK said: “Patient safety is of the utmost importance to GSK and we take all possible signals related to the safety of our medicines seriously.”

Leave a Reply

Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read